Probiotics and Prebiotics-Prevention and Therapy in Atopic Eczema

Bioactive Foods in Promoting Health

Volumn , Issue , 2010, Pages 279-292

  Bunselmeyer, Britta ^a   Buddendick, Kirsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884430084     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374938-3.00019-0     Document Type: Chapter

References (46)

1. Williams H., Robertson C., Stewart A., et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. The Journal of Allergy and Clinical Immunology 1999, 103:125-138.
2. Nickel R., Lau S., Niggemann B., et al. Messages from the German Multicentre Allergy Study. Pediatric Allergy and Immunology 2002, 13(Suppl. 15):7-10.
3. Ninan T.K., Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: Evidence from two surveys 25 years apart. BMJ 1992, 304:873-875.
4. Schultz L.F., Diepgen T., Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. Journal of the American Academy of Dermatology 1996, 34:760-764.
5. Strachan D.P. Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260.
6. Zirngibl A., Franke K., Gehring U., et al. Exposure to pets and atopic dermatitis during the first two years of life. A cohort study. Pediatric Allergy and Immunology 2002, 13:394-401.
7. Schoetzau A., Filipiak-PittroffB., Franke K., et al. Effect of exclusive breast-feeding and early solid food avoidance on the incidence of atopic dermatitis in high-risk infants at 1 year of age. Pediatric Allergy and Immunology 2002, 13:234-242.
8. von Berg A., Filipiak-PittroffB., Kramer U., et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: Long-term results from the German Infant Nutritional Intervention Study (GINI). The Journal of Allergy and Clinical Immunology 2008, 121:1442-1447.
9. Kalliomaki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001, 357:1076-1079.
10. Pochard P., Gosset P., Grangette C., et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. The Journal of Allergy and Clinical Immunology 2002, 110:617-623.
11. Shida K., Makino K., Morishita A., et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. International Archives of Allergy and Immunology 1998, 115:278-287.
12. Pelto L., Isolauri E., Lilius E.M., et al. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clinical and Experimental Allergy 1998, 28:1474-1479.
13. Donnet-Hughes A., Rochat F., Serrant P., et al. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: Effective dose. Journal of Dairy Science 1999, 82:863-869.
14. Schiffrin E.J., Rochat F., Link-Amster H., et al. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. Journal of Dairy Science 1995, 78:491-497.
15. Fukushima Y., Kawata Y., Hara H., Terada A., Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. International Journal of Food Microbiology 1998, 42:39-44.
16. Rautava S., Arvilommi H., Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Pediatric Research 2006, 60:221-224.
17. Paineau D., Carcano D., Leyer G., et al. Effects of seven potential probiotic strains on specific immune responses in healthy adults: A double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 2008, 53:107-113.
18. Kalliomaki M., Salminen S., Poussa T., et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361:1869-1871.
19. Kopp M.V., Hennemuth I., Heinzmann A., Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics 2008, 121:E850-E856.
20. Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. The Journal of Allergy and Clinical Immunology 2002, 109:119-121.
21. Kalliomaki M., Ouwehand A., Arvilommi H., et al. Transforming growth factor-beta in breast milk: A potential regulator of atopic disease at an early age. The Journal of Allergy and Clinical Immunology 1999, 104:1251-1257.
22. Huurre A., Laitinen K., Rautava S., et al. Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: A double-blind placebo-controlled study. Clinical and Experimental Allergy 2008, 38:1342-1348.
23. Prescott S.L., Wickens K., Westcott L., et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clinical and Experimental Allergy 2008, 38:1606-1614.
24. Prescott S.L., Macaubas C., Smallacombe T., et al. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999, 353:196-200.
25. Suzuki S., Shimojo N., Tajiri Y., et al. Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan. Clinical and Experimental Allergy 2007, 37:506-511.
26. He F., Ouwehand A.C., Isolauri E., et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 2001, 30:43-47.
27. Lahtinen S.J., Boyle R.J., Kivivuori S., et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. The Journal of Allergy and Clinical Immunology 2009, 123:499-501.
28. Kuitunen M., Kukkonen K., Juntunen-Backman K., et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. The Journal of Allergy and Clinical Immunology 2009, 123:335-341.
29. Majamaa H., Isolauri E. Probiotics: A novel approach in the management of food allergy. The Journal of Allergy and Clinical Immunology 1997, 99:179-185.
30. Anonymous. (1993). Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology, 186, 23-31.
31. Isolauri E., Arvola T., Sutas Y., et al. Probiotics in the management of atopic eczema. Clinical and Experimental Allergy 2000, 30:1604-1610.
32. Rosenfeldt V., Benfeldt E., Nielsen S.D., et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. The Journal of Allergy and Clinical Immunology 2003, 111:389-395.
33. Hol J., van Leer E.H., Elink Schuurman B.E., et al. The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial. The Journal of Allergy and Clinical Immunology 2008, 121:1448-1454.
34. Helin T., Haahtela S., Haahtela T. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: A placebo-controlled double-blind study. Allergy 2002, 57:243-246.
35. Boehm G., Lidestri M., Casetta P., et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Archives of Disease in Childhood 2002, 86:178-181.
36. Moro G., Minoli I., Mosca M., et al. Dosage-related bifidogenic effects of galacto- and fructo-oligosaccharides in formula-fed term infants. Journal of Pediatric Gastroenterology and Nutrition 2002, 34:291-295.
37. Kunz C., RudloffS., Baier W., et al. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annual review of nutrition 2000, 20:699-722.
38. Bjorksten B., Sepp E., Julge K., et al. Allergy development and the intestinal microflora during the first year of life. The Journal of Allergy and Clinical Immunology 2001, 108:516-520.
39. Kleessen B., Bunke H., Tovar K., et al. Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatrica 1995, 84:1347-1356.
40. Watanabe S., Narisawa Y., Arase S., et al. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. The Journal of Allergy and Clinical Immunology 2003, 111:587-591.
41. Moro G., Arslanoglu S., Stahl B., et al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Archives of Disease in Childhood 2006, 91:814-819.
42. Arslanoglu S., Moro G.E., Schmitt J., et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. The Journal of Nutrition 2008, 138:1091-1095.
43. van Hoffen E., Ruiter B., Faber J., et al. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 2009, 64:484-487.
44. Bunout D., Hirsch S., Pia D.l. M., et al. Effects of prebiotics on the immune response to vaccination in the elderly. Journal of Parenteral and Enteral Nutrition 2002, 26:372-376.
45. Cummings J.H., Christie S., Cole T.J. A study of fructo oligosaccharides in the prevention of travellers' diarrhoea. Alimentary Pharmacology & Therapeutics 2001, 15:1139-1145.
46. Schillinger U. Isolation and identification of lactobacilli from novel-type probiotic and mild yoghurts and their stability during refrigerated storage. International Journal of Food Microbiology 1999, 47:79-87.